← Back to Search

Behavioral Intervention

Cognitive Training for Gynecologic Cancers (GYNCOG Trial)

N/A
Waitlist Available
Led By Emma Barber, MD, MS
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female; ≥18 years of age
Be older than 18 years old
Must not have
Patients who have not received chemotherapy
Patients with non-gynecologic causes of incurable metastatic cancers
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to test a personalized cognitive training program at home for gynecologic cancer patients who have finished chemotherapy and are facing memory and thinking issues related to cancer treatment.

Who is the study for?
This trial is for women over 18 with gynecologic cancers like ovarian, endometrial, cervical, or vulvar cancer who've finished chemotherapy and feel they have cognitive issues. They must speak English and have internet access to do assessments but can't join if they're pregnant, imprisoned, using other cognitive programs, or have conditions like dementia affecting their cognition.
What is being tested?
The study tests a home-based cognitive training program tailored for patients with gynecologic cancer who've completed chemotherapy and report thinking problems. It aims to see how well the intervention works in improving cognitive function post-treatment.
What are the potential side effects?
Since this is a non-drug intervention focusing on cognitive training exercises done at home via the internet, there are no typical medication side effects; however, participants may experience frustration or fatigue related to the exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman aged 18 or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have not undergone chemotherapy.
Select...
My cancer is incurable, has spread, and is not related to gynecologic origins.
Select...
I am not participating in other cognitive studies or using brain training apps.
Select...
I have a learning disability or I do not want to participate in technology-based cognitive training.
Select...
I am unable to make my own medical decisions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence
Assessment Compliance
Secondary study objectives
Acceptability
Change in Anxiety
Change in Depression
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: GYNCOG InterventionExperimental Treatment1 Intervention
Participants in the GYNCOG arm will be asked to participate in a home-based cognitive training program utilizing BrainHQ on study-provided tablets.
Group II: Control GroupActive Control1 Intervention
Patients in the Control Group arm will receive usual care with no cognitive intervention.

Find a Location

Who is running the clinical trial?

Friends of PrenticeOTHER
5 Previous Clinical Trials
824 Total Patients Enrolled
Northwestern UniversityLead Sponsor
1,645 Previous Clinical Trials
958,534 Total Patients Enrolled
Emma Barber, MD, MSPrincipal InvestigatorNorthwestern University
4 Previous Clinical Trials
324 Total Patients Enrolled
~40 spots leftby Dec 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top